BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10526251)

  • 21. Hyperthyroxinemia and Hypercortisolemia due to Familial Dysalbuminemia.
    Moran C; Seger C; Taylor K; Oddy S; Burling K; Rajanayagam O; Fairall L; McGowan A; Lyons G; Halsall D; Gurnell M; Schwabe J; Chatterjee K; Strey C
    Thyroid; 2020 Nov; 30(11):1681-1684. PubMed ID: 32669045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype.
    Petersen CE; Ha CE; Harohalli K; Park DS; Feix JB; Isozaki O; Bhagavan NV
    Clin Chem; 1999 Aug; 45(8 Pt 1):1248-54. PubMed ID: 10430791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial dysalbuminemic hyperthyroxinemia in pregnancy.
    Sachmechi I; Schussler GC
    Eur J Endocrinol; 1995 Dec; 133(6):729-31. PubMed ID: 8548059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial Dysalbuminemic Hyperthyroxinemia (FDH), Albumin Gene Variant (R218S), and Risk of Miscarriages in Offspring.
    Lai S; Gopalakrishnan G; Li J; Liu X; Chen Y; Wen Y; Zhang S; Huang B; Phornphutkul C; Liu S; Kuang J
    Am J Med Sci; 2020 Nov; 360(5):566-574. PubMed ID: 32665066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid molecular diagnosis of
    Abali S; Yavas Abali Z; Yararbas K; Semiz S
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1201-1205. PubMed ID: 34142517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial dysalbuminemic hyperthyroxinemia.
    Jensen IW; Faber J
    Acta Med Scand; 1987; 221(5):469-73. PubMed ID: 3111180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of familial dysalbuminemic hyperthyroxinemia (FDH) in Japan: FDH as a possible differential diagnosis of syndrome of inappropriate secretion of thyroid-stimulating hormone (SITSH).
    Kobayashi S; Yoshimura Noh J; Shimizu T; Sato T; Kurihara I; Sugino K; Itoh H; Ito K
    Endocr J; 2017 Feb; 64(2):207-212. PubMed ID: 27904073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of serum protein binding of thyroxine in a hypothyroid patient with familial dysalbuminemic hyperthyroxinemia.
    Premachandra BN; Wortsman J; Williams IK
    Clin Biochem; 1996 Feb; 29(1):85-8. PubMed ID: 8929830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of familial dysalbuminemic hyperthyroxinemia in Chinese patients and comparison of free thyroxine in three immunoassay methods.
    Zhao L; Zhou Y; Huang F; He X; Mei G; Wang S; Zhao Y
    Front Endocrinol (Lausanne); 2023; 14():1102777. PubMed ID: 36864842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence investigations of albumin from patients with familial dysalbuminemic hyperthyroxinemia.
    Dughi C; Bhagavan NV; Jameson DM
    Photochem Photobiol; 1993 Mar; 57(3):416-9. PubMed ID: 8475173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics.
    Petersen CE; Ha CE; Harohalli K; Park DS; Bhagavan NV
    Chem Biol Interact; 2000 Feb; 124(3):161-72. PubMed ID: 10728776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Point mutations behind familial dysalbuminemic hyperthyroxinemia].
    Nørby S
    Ugeskr Laeger; 2008 Jun; 170(25):2259; author reply 2260. PubMed ID: 18581650
    [No Abstract]   [Full Text] [Related]  

  • 33. Normal cellular uptake of thyroxine from serum of patients with familial dysalbuminemic hyperthyroxinemia or elevated thyroxine-binding globulin.
    Sarne DH; Refetoff S
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1166-70. PubMed ID: 3142912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing.
    Arevalo G
    Clin Chem; 1991 Aug; 37(8):1430-1. PubMed ID: 1868606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A four generation study of familial dysalbuminemic hyperthyroxinemia: diagnosis in the presence of an acquired excess of thyroxine-binding globulin.
    Yeo PP; Yabu Y; Etzkorn JR; Rajatanavin R; Braverman LE; Ingbar SH
    J Endocrinol Invest; 1987 Feb; 10(1):33-8. PubMed ID: 3110251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia.
    Schoenmakers N; Moran C; Campi I; Agostini M; Bacon O; Rajanayagam O; Schwabe J; Bradbury S; Barrett T; Geoghegan F; Druce M; Beck-Peccoz P; O'Toole A; Clark P; Bignell M; Lyons G; Halsall D; Gurnell M; Chatterjee K
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1381-6. PubMed ID: 24646103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroxin binding by human serum albumin after denaturation of the thyroxin-binding globulin in familial dysalbuminemic hyperthyroxinemia.
    Arevalo G
    Clin Chem; 1988 Apr; 34(4):705-8. PubMed ID: 3129213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of familial dysalbuminemic hyperthyroxinemia and investigation of the nature of the variant albumin.
    Takamatsu J; Ohsawa N
    Bull Osaka Med Coll; 1990 Nov; 36(1-2):35-45. PubMed ID: 2135643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid function tests in patients with familial dysalbuminaemic hyperthyroxinaemia (FDH).
    Stewart MF; Ratcliffe WA; Roberts I
    Ann Clin Biochem; 1986 Jan; 23 ( Pt 1)():59-64. PubMed ID: 3767254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial dysalbuminemic hyperthyroxinemia associated with primary thyroid disease.
    Young RA; Stoffer SS; Braverman LE
    Am J Med; 1987 Feb; 82(2):221-3. PubMed ID: 3812513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.